Trastuzumab for the treatment of HER2-positive metastatic gastric cancer

  • Technology appraisal guidance
  • TA208
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that trastuzumab is recommended as an option for treating HER2-positive metastatic gastric cancer.

ISBN: 978-1-4731-6652-3